Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis

2009 ◽  
Vol 29 (4) ◽  
pp. 431-436 ◽  
Author(s):  
Katsuya Suzuki ◽  
Hideto Kameda ◽  
Koichi Amano ◽  
Hayato Nagasawa ◽  
Hirofumi Takei ◽  
...  
2014 ◽  
Vol 42 (2) ◽  
pp. 193-195 ◽  
Author(s):  
Rossella Reggia ◽  
Franco Franceschini ◽  
Angela Tincani ◽  
Ilaria Cavazzana

Objective.Subcutaneous (SC) abatacept (ABA) is comparable to intravenous (IV) formulation in terms of efficacy and safety profile. Our work analyzed the switch to SC formulation from IV administration in patients with rheumatoid arthritis.Methods.Fifty-one patients treated with SC ABA were included. Clinical data were obtained from clinical charts.Results.Fourteen patients relapsed and needed to return to the IV administration. Neither clinical and laboratory features nor the previous therapies were identified as risk factors for SC formulation inefficacy. Disease activity decreased after the return to IV infusions.Conclusion.SC ABA showed a risk of relapse in 27% of cases. The reinsertion of the IV administration quickly reinstated disease control.


2016 ◽  
Vol 11 (1) ◽  
Author(s):  
Sharon Samueli ◽  
Klaus Abraham ◽  
Anastasia Dressler ◽  
Gudrun Gröppel ◽  
Angelika Mühlebner-Fahrngruber ◽  
...  

Digestion ◽  
2016 ◽  
Vol 93 (3) ◽  
pp. 193-201 ◽  
Author(s):  
Shinya Sugimoto ◽  
Makoto Naganuma ◽  
Hiroki Kiyohara ◽  
Mari Arai ◽  
Keiko Ono ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document